Autolus Therapeutics plc (AUTL) PT Raised to $2.70 at Goldman Sachs
Tweet
Share
E-mailGet Alerts AUTL Hot Sheet
Price: $2.15 -3.15%
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Goldman Sachs analyst Graig Suvannavejh raised the price target on Autolus Therapeutics plc (NASDAQ: AUTL) to $2.70 (from $2.20) while maintaining a Neutral rating.
You May Also Be Interested In
- Autolus Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
- Zedcor Inc (ZDC:CN) PT Raised to Cdn$7.75 at Desjardins
- Apollo Hospitals (APLH:IN) PT Raised to INR8,500 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
